Fidelity Global Health Care A-Acc-EUR

The fund is an Equity fund and aims to provide investors with long-term capital growth, principally (i.e. at least 70% (and normally 75%) of the fund’s assets) through investment in equity securities of companies throughout the world that are involved in the design, manufacture, or sale of products and services used in health care, medicine or biotechnology.

Fidelity Global Health Care A-Acc-EUR

The fund is an Equity fund and aims to provide investors with long-term capital growth, principally (i.e. at least 70% (and normally 75%) of the fund’s assets) through investment in equity securities of companies throughout the world that are involved in the design, manufacture, or sale of products and services used in health care, medicine or biotechnology.

16.81%

3 Years Annualised

1.08

Sharpe Ratio

€1,253.74

Fund Size (Mil)

Fund Type

Equity Fund

Geographies

Global

Industry Focus

Health Care

Fund Style

Blend

Distribution

Not applicable

Inception Date

01/09/2000

Track Records

As part of Venture Smart’s rigorous selection and due diligence process, we analyse the fund’s investment record for the specific fund strategy in great detail. We scrutinize investment level performance, comparing investment strategy with results and understanding the team’s actions to drive overperformance and manage under performance.

Terms & Legal

Investment Manager

Fidelity International

Fund Manager

Alex Gold,
Judith Finegold

Management fee

1.50%

Performance fee

0.00%

Max Initial Charge

5.25%

Redemption Fee

Not Applicable

Remarks

•You generally buy, redeem or switch shares at the fund’s next-determined net asset value after we receive your request, directly or via a distributor, in good order at or before 5.00 p.m. Hong Kong time on a dealing day, being the fund’s dealing cut-off time. Before placing your orders, please check with your distributor for the distributor’s internal dealing cut-off time (which may be earlier than the fund’s dealing cut-off time).
• The net asset value of this fund is calculated and the price of shares is published each business day. Net asset value of the fund will be published in the South China Morning Post and the Hong Kong Economic Times.

Important Information

• This fund invests primarily in equity securities of companies throughout the world which are involved in the design, manufacture, or sale of products and services used for or in connection with health care, medicine or biotechnology.
• The fund is subject to equities risk, risk to capital and income, foreign currency risk, valuation risk and stock/issuer concentration risk. The fund may invest in a single sector and may have greater exposures to the market, liquidity, tax, legal, regulatory, and economic risks of those sectors.
• The fund’s net derivative exposure may be up to 50% of its NAV, the use of derivatives may involve liquidity risk, counterparty credit risk, volatility risk, valuations risks and over-the-counter transaction risk, at times. Exposure to financial derivative instruments and its leverage element may lead to a high risk of significant loss by the fund.
• Investors may suffer substantial loss of their investments in the fund. Investor should not invest in the fund solely based on the information provided in this document and should read the offering documents, including Product Key Facts (including the risk factors) for details.

Leave your details to learn more

  •  
Disclaimer

Warning statement

Past performance is not a guide to future performance. Returns may increase or decrease as a result of currency fluctuations. All performance data is calculated NAV to NAV, net of fees, dividends reinvested and does not take account of commissions and costs incurred on the issue and redemption of units. US/Hong Kong dollar-based investors are exposed to currency fluctuations where funds are denominated in currencies other than US/Hong Kong dollars.

Performance data is not available if a share class is less than 12 calendar months old. However performance data for other share classes of the same fund will be available in the factsheet, provided such share classes are more than 12 calendar months old. Performance between share classes may differ due to factors such as hedging strategies and fees.

Important Information

  • The investment may involve risks that could result in loss of part or entire amount of investors’ investment.
  • Investors should not solely rely on this document to make any investment decision. You should read and understand the offering documents for further fund details including risk factors.
logo_only
VSFG is committed to helping individuals, families and corporations meet their financial objectives.

Contact

Headquarters and principal place of business

23/F, Lee Garden Five, 18 Hysan Avenue, Causeway Bay, Hong Kong

Causeway Bay Office

12/F, Phase II, China Taiping Tower, 8 Sunning Road, Causeway Bay, Hong Kong